USPTO serial 79445032
MQS
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- EISNACH, MICHAEL PATRICK
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with MQS?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
Owner
Molecular Quantum Solutions ApS
XP
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for the digitalisation and management of chemical and pharmaceutical laboratory processes; downloadable software for molecular simulation, analysis and screening; downloadable software for the calculation of chemical, physical and biological properties of molecules by means of computer simulations; downloadable electronic databases featuring chemical, biological and materials-science data; downloadable computer software for quantum computing, artificial intelligence and machine learning. | ACTIVE | — |
| 040 | Custom manufacturing of chemicals for others; custom manufacturing of pharmaceuticals, biopharmaceuticals, ionic liquids, lipids, nano-lipids, peptides for others. | ACTIVE | — |
| 042 | Laboratory digitalisation services, namely design and implementation of computerised workflows for chemical and pharmaceutical laboratories; screening of chemical compounds and biological molecules for scientific research purposes; calculation of chemical, physical and biological properties of molecules by means of computer simulations (software as a service, SaaS), in particular computer simulations based on quantum computing, artificial intelligence or other advance computing techniques; software as a service (SaaS) featuring software for the calculation of chemical, physical and biological properties of molecules by means of computer simulations, in particular computer simulations based on quantum computing, artificial intelligence or other advanced computing techniques; software as a service (SaaS) featuring software for quantum computing and artificial-intelligence-based analysis of laboratory and molecular data; scientific testing of chemical substances to determine and control their properties, including using automated and modular laboratory systems and robot-controlled laboratory equipment; server hosting; rental of web servers; provision of computing and storage capacity via cloud computing; platform as a service (PaaS) featuring software platforms for high-performance and quantum computing workflows; design, development, installation, maintenance and updating of computer software for laboratory automation, molecular screening and data analysis; design of chemical compounds and biological molecules possessing predefined chemical, physical or biological properties; quantum computing services, namely providing access to quantum computing hardware and quantum algorithms via cloud computing; providing temporary use of non-downloadable software for the calculation and simulation of chemical, physical and biological properties of molecules, including by means of quantum computing, artificial intelligence or other advanced computing techniques; providing temporary use of non-downloadable software for the digitalisation and management of chemical and pharmaceutical laboratory processes; providing temporary use of non-downloadable software for molecular simulation, analysis and screening; providing temporary use of non-downloadable electronic databases featuring chemical, biological and materials-science data; providing temporary use of non-downloadable software for quantum computing, artificial intelligence and machine learning; infrastructure as a service (IaaS); cloud computing services featuring virtualised computing environments for scientific simulations and data analysis; configuration and integration of on-premise and cloud-based software for laboratory digitalisation and molecular simulation; data hosting, data warehousing and electronic storage of scientific, chemical and pharmaceutical data; consultancy in the field of scientific and technological services relating to laboratory automation, quantum computing and artificial intelligence. | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Jul 23, 2026 | RFNT | REFUSAL PROCESSED BY IB |
| Jul 7, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Jul 7, 2026 | RFRR | REFUSAL PROCESSED BY MPU |
| May 20, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| May 19, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| May 13, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Apr 23, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED |
| Mar 5, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Mar 5, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 5, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB |